Market Study: Moneyball for Clinical Trial Agreements

What You’ll Gain From This Report

Analysis of some of the most frequently contested clauses—and how they’re commonly resolved.

A data-backed breakdown of recurring CTA negotiation trends—showing where most discussions end up and which points truly matter.

A framework to reduce friction, accelerate trial timelines, and launch clinical research faster.

By starting from prevailing market norms—instead of repeatedly rediscovering them—sites and sponsors can cut down negotiation cycles and ultimately move trials forward faster.